公开(公告)号：US20180311298A1

公开(公告)日：2018-11-01

申请号：US16028812

申请日：2018-07-06

Applicant: GDB Patent Holdings, LLC

Inventor： Gregory Blackman

IPC: A61K36/752 ,  A61K45/06 ,  A23L33/175 ,  A61K36/28 ,  A61K31/732 ,  A61K31/714 ,  A61K31/525 ,  A61K31/519 ,  A61K31/51 ,  A61K31/455 ,  A61K31/4415 ,  A61K31/4375 ,  A61K31/4015 ,  A61K31/352 ,  A61K31/198 ,  A61K31/197 ,  A61K31/137 ,  A61K31/133 ,  A61K9/08 ,  A61K9/00 ,  A61K36/73 ,  A23L33/16 ,  A23L33/15 ,  A23L33/21 ,  A61K8/31 ,  A61K8/19 ,  A61K8/67

CPC classification number: A61K36/752 ,  A23L33/15 ,  A23L33/16 ,  A23L33/175 ,  A23L33/21 ,  A23V2002/00 ,  A61K8/19 ,  A61K8/31 ,  A61K8/67 ,  A61K8/673 ,  A61K9/0095 ,  A61K9/08 ,  A61K31/133 ,  A61K31/137 ,  A61K31/197 ,  A61K31/198 ,  A61K31/352 ,  A61K31/4015 ,  A61K31/4375 ,  A61K31/4415 ,  A61K31/455 ,  A61K31/51 ,  A61K31/519 ,  A61K31/525 ,  A61K31/714 ,  A61K31/732 ,  A61K36/28 ,  A61K36/73 ,  A61K45/06 ,  A61K2300/00 ,  A23V2200/334 ,  A23V2250/0616 ,  A23V2250/0634 ,  A23V2250/16 ,  A23V2250/161 ,  A23V2250/1614 ,  A23V2250/21168 ,  A23V2250/5072 ,  A23V2250/7042 ,  A23V2250/7044 ,  A23V2250/7046 ,  A23V2250/705 ,  A23V2250/7052 ,  A23V2250/706 ,  A23V2250/0652 ,  A23V2250/7054 ,  A23V2250/7058

Abstract: The present invention relates to a composition, and methods of using the composition, for minimizing the harmful effects associated with alcohol consumption. The composition includes a plurality of ingredients, which when combined, have the unexpected effect of increasing one or more metabolic pathways in the individual. As the metabolic rate is increased, alcohol is burned off, or utilized as energy source, and occurs at a considerably much faster rate than under normal physiological means. It is believed that the composition may have an effect on the brain causing it to increase metabolic rates. By administering the composition to an inebriated individual, the rate at which a person sobers up, occurs at a faster rate than would occur under normal physiological time frames.

公开(公告)号：US09861575B2

公开(公告)日：2018-01-09

申请号：US13668558

申请日：2012-11-05

Applicant: AJINOMOTO CO., INC.

Inventor： Kazuhiro Abiko ,  Toshiyuki Katsura

IPC: A61K9/08 ,  A61K9/00 ,  A61K31/197 ,  A61K31/375 ,  A61K31/4188 ,  A61K31/4415 ,  A61K31/455 ,  A61K31/51 ,  A61K31/525 ,  A61K31/7004 ,  A61K31/714 ,  A61K33/06 ,  A61K33/20 ,  A61K33/30 ,  A23L33/15

CPC classification number: A61K9/0019 ,  A23L33/15 ,  A23V2002/00 ,  A61K31/197 ,  A61K31/375 ,  A61K31/4188 ,  A61K31/4415 ,  A61K31/455 ,  A61K31/51 ,  A61K31/525 ,  A61K31/7004 ,  A61K31/714 ,  A61K33/06 ,  A61K33/20 ,  A61K33/30 ,  A61K2300/00 ,  A23V2250/7042 ,  A23V2250/7044 ,  A23V2250/7046 ,  A23V2250/705 ,  A23V2250/7052 ,  A23V2250/7056 ,  A23V2250/706 ,  A23V2250/708 ,  A23V2250/72

Abstract: A nutrition infusion is provided for administration through a peripheral vein that contains a vitamin B group and vitamin C stably and includes two solutions of a sugar solution and an amino acid solution. In the nutrition infusion for administration through a peripheral vein, the sugar solution contains vitamin B1, vitamin B12, and pantothenic acid and has a pH of 4.7 to 5.5, and the amino acid solution contains vitamin B2, folic acid, vitamin C, and biotin and has a pH of 7.0 to 7.5.

公开(公告)号：US09661874B2

公开(公告)日：2017-05-30

申请号：US13833765

申请日：2013-03-15

Applicant: Mead Johnson Nutrition Company

Inventor： Dattatreya Banavara ,  John Alvey ,  Juan Gonzalez

IPC: A23L33/115 ,  A23L33/00

CPC classification number: A23L33/115 ,  A23L33/40 ,  A23V2002/00 ,  A23V2250/1578 ,  A23V2250/1588 ,  A23V2250/1592 ,  A23V2250/1598 ,  A23V2250/16 ,  A23V2250/161 ,  A23V2250/1612 ,  A23V2250/1614 ,  A23V2250/1618 ,  A23V2250/1642 ,  A23V2250/1842 ,  A23V2250/1866 ,  A23V2250/1868 ,  A23V2250/1876 ,  A23V2250/1882 ,  A23V2250/194 ,  A23V2250/28 ,  A23V2250/304 ,  A23V2250/54252 ,  A23V2250/612 ,  A23V2250/702 ,  A23V2250/7042 ,  A23V2250/7044 ,  A23V2250/7046 ,  A23V2250/7052 ,  A23V2250/7056 ,  A23V2250/706 ,  A23V2250/708 ,  A23V2250/71 ,  A23V2250/712 ,  A23V2250/714 ,  A23V2250/72

Abstract: The present disclosure relates to a lipid source for nutritional compositions, comprising an enriched lipid fraction which comprises structured fat globules. The enriched lipid fraction provides fat globules having a desired size and fatty acid composition and may be stabilized by components such as phospholipids, cholesterol, milk-fat globule membrane protein and combinations thereof. Additionally, the disclosure relates to methods of supporting lipid digestion in a pediatric subject by providing a nutritional composition comprising an enriched lipid fraction having structured fat globules that are more accessible to lipases. The chemical composition, size and structure of the fat globules may improve digestion. The disclosed nutritional compositions may provide additive and or/synergistic beneficial health effects.

公开(公告)号：US20170079935A1

公开(公告)日：2017-03-23

申请号：US15368167

申请日：2016-12-02

Applicant: NESTEC S.A.

Inventor： Eduardo Schiffrin ,  Viral Brahmbhatt ,  Francois-Pierre Martin ,  Jalil Benyacoub

IPC: A61K31/122 ,  A61K31/59 ,  A61K31/202 ,  A61K31/355 ,  A61K31/375 ,  A61K31/51 ,  A61K31/525 ,  A61K31/197 ,  A61K31/4415 ,  A61K31/714 ,  A61K31/455 ,  A61K31/519 ,  A61K31/14 ,  A61K31/4188 ,  A61K31/015 ,  A61K31/07 ,  A23L33/00 ,  A23L33/15 ,  A23L33/155 ,  A23L33/175 ,  A23L33/19 ,  A23L33/12 ,  A23L2/66 ,  A23L2/38 ,  A61K38/17

CPC classification number: A61K31/122 ,  A23L2/38 ,  A23L2/66 ,  A23L5/40 ,  A23L33/10 ,  A23L33/12 ,  A23L33/135 ,  A23L33/15 ,  A23L33/155 ,  A23L33/16 ,  A23L33/175 ,  A23L33/19 ,  A23L33/21 ,  A23L33/30 ,  A23L33/40 ,  A23V2002/00 ,  A23V2200/00 ,  A61K31/015 ,  A61K31/07 ,  A61K31/14 ,  A61K31/197 ,  A61K31/20 ,  A61K31/202 ,  A61K31/355 ,  A61K31/375 ,  A61K31/4188 ,  A61K31/4415 ,  A61K31/455 ,  A61K31/51 ,  A61K31/519 ,  A61K31/525 ,  A61K31/59 ,  A61K31/714 ,  A61K33/00 ,  A61K33/04 ,  A61K33/06 ,  A61K33/16 ,  A61K33/18 ,  A61K33/20 ,  A61K33/24 ,  A61K33/26 ,  A61K33/30 ,  A61K33/32 ,  A61K33/34 ,  A61K33/42 ,  A61K38/1709 ,  A61K45/06 ,  A23V2200/32 ,  A23V2250/1578 ,  A23V2250/1582 ,  A23V2250/1586 ,  A23V2250/1588 ,  A23V2250/159 ,  A23V2250/1592 ,  A23V2250/1598 ,  A23V2250/16 ,  A23V2250/1608 ,  A23V2250/161 ,  A23V2250/1612 ,  A23V2250/1614 ,  A23V2250/1618 ,  A23V2250/1626 ,  A23V2250/1642 ,  A23V2250/1872 ,  A23V2250/1874 ,  A23V2250/1878 ,  A23V2250/1882 ,  A23V2250/54246 ,  A23V2250/702 ,  A23V2250/7042 ,  A23V2250/7044 ,  A23V2250/7046 ,  A23V2250/705 ,  A23V2250/7052 ,  A23V2250/7056 ,  A23V2250/708 ,  A23V2250/71 ,  A23V2250/712 ,  A23V2250/7142 ,  A23V2250/7144 ,  A23V2250/72

Abstract: A nutritional composition promotes musculoskeletal health in patients with inflammatory bowel disease. The nutritional composition contains casein protein, vitamin D, alpha-linolenic acid, and vitamin K in a ratio of vitamin K1:vitamin K2 between 3:1 to 1:3 and the vitamin K providing between 3.5-20 μg/100 cal of the nutritional composition. A pharmaceutical formulation, a nutritional formulation, a tube-feed formulation, a dietary supplement, a functional food, a beverage product or a combination thereof comprising the nutritional composition is also disclosed. A method for improving musculoskeletal health is also disclosed.

公开(公告)号：US20160158304A1

公开(公告)日：2016-06-09

申请号：US14933286

申请日：2015-11-05

Applicant: Gregory Blackman

Inventor： Gregory Blackman

IPC: A61K36/752 ,  A61K45/06 ,  A61K9/08 ,  A61K31/4375

CPC classification number: A61K36/752 ,  A23L33/15 ,  A23L33/16 ,  A23L33/175 ,  A23L33/21 ,  A23V2002/00 ,  A61K8/19 ,  A61K8/31 ,  A61K8/67 ,  A61K8/673 ,  A61K9/0095 ,  A61K9/08 ,  A61K31/133 ,  A61K31/137 ,  A61K31/197 ,  A61K31/198 ,  A61K31/352 ,  A61K31/4015 ,  A61K31/4375 ,  A61K31/4415 ,  A61K31/455 ,  A61K31/51 ,  A61K31/519 ,  A61K31/525 ,  A61K31/714 ,  A61K31/732 ,  A61K36/28 ,  A61K36/73 ,  A61K45/06 ,  A61K2300/00 ,  A23V2200/334 ,  A23V2250/0616 ,  A23V2250/0634 ,  A23V2250/16 ,  A23V2250/161 ,  A23V2250/1614 ,  A23V2250/21168 ,  A23V2250/5072 ,  A23V2250/7042 ,  A23V2250/7044 ,  A23V2250/7046 ,  A23V2250/705 ,  A23V2250/7052 ,  A23V2250/706 ,  A23V2250/0652 ,  A23V2250/7054 ,  A23V2250/7058

Abstract: The present invention relates to a composition, and methods of using the composition, for minimizing the harmful effects associated with alcohol consumption. The composition includes a plurality of ingredients, which when combined, have the unexpected effect of increasing one or more metabolic pathways in the individual. As the metabolic rate is increased, alcohol is burned off, or utilized as energy source, and occurs at a considerably much faster rate than under normal physiological means. It is believed that the composition may have an effect on the brain causing it to increase metabolic rates. By administering the composition to an inebriated individual, the rate at which a person sobers up, occurs at a faster rate than would occur under normal physiological time frames.

公开(公告)号：US09161565B1

公开(公告)日：2015-10-20

申请号：US14336991

申请日：2014-07-21

Applicant: Mark S. Bezzek

Inventor： Mark S. Bezzek

IPC: A23L1/30 ,  A61K36/889 ,  A61K36/258 ,  A61K33/22 ,  A61K31/566 ,  A61K31/57 ,  A61K31/404 ,  A61K31/352 ,  A61K31/05 ,  A61K31/375 ,  A61K36/48 ,  A61K36/185 ,  A61K36/15 ,  A61K31/475 ,  A61K31/575 ,  A61K36/73 ,  A23L1/304 ,  A23L1/302

CPC classification number: A23L1/30 ,  A23L33/10 ,  A23L33/105 ,  A23L33/12 ,  A23L33/15 ,  A23L33/155 ,  A23L33/16 ,  A23L33/18 ,  A23V2002/00 ,  A61K8/31 ,  A61K8/347 ,  A61K8/35 ,  A61K8/355 ,  A61K8/361 ,  A61K8/41 ,  A61K8/4986 ,  A61K8/63 ,  A61K8/64 ,  A61K8/671 ,  A61K8/675 ,  A61K8/676 ,  A61K8/735 ,  A61K8/97 ,  A61K31/05 ,  A61K31/085 ,  A61K31/12 ,  A61K31/122 ,  A61K31/185 ,  A61K31/198 ,  A61K31/205 ,  A61K31/352 ,  A61K31/355 ,  A61K31/375 ,  A61K31/385 ,  A61K31/404 ,  A61K31/4172 ,  A61K31/4188 ,  A61K31/4415 ,  A61K31/4745 ,  A61K31/475 ,  A61K31/48 ,  A61K31/566 ,  A61K31/57 ,  A61K31/575 ,  A61K31/593 ,  A61K31/675 ,  A61K31/736 ,  A61K33/22 ,  A61K33/24 ,  A61K33/30 ,  A61K33/32 ,  A61K36/03 ,  A61K36/15 ,  A61K36/185 ,  A61K36/258 ,  A61K36/27 ,  A61K36/42 ,  A61K36/45 ,  A61K36/47 ,  A61K36/48 ,  A61K36/484 ,  A61K36/54 ,  A61K36/68 ,  A61K36/73 ,  A61K36/82 ,  A61K36/889 ,  A61K36/8962 ,  A61K36/9066 ,  A61Q19/08 ,  A23V2200/322 ,  A23V2250/026 ,  A23V2250/0634 ,  A23V2250/1572 ,  A23V2250/1578 ,  A23V2250/1586 ,  A23V2250/1588 ,  A23V2250/1598 ,  A23V2250/16 ,  A23V2250/161 ,  A23V2250/1612 ,  A23V2250/1614 ,  A23V2250/1626 ,  A23V2250/1642 ,  A23V2250/1866 ,  A23V2250/2106 ,  A23V2250/2112 ,  A23V2250/21166 ,  A23V2250/212 ,  A23V2250/213 ,  A23V2250/214 ,  A23V2250/304 ,  A23V2250/31 ,  A23V2250/314 ,  A23V2250/626 ,  A23V2250/641 ,  A23V2250/702 ,  A23V2250/7042 ,  A23V2250/7044 ,  A23V2250/705 ,  A23V2250/7052 ,  A23V2250/7056 ,  A23V2250/706 ,  A23V2250/708 ,  A23V2250/7106 ,  A23V2250/712 ,  A23V2250/7144 ,  A23V2250/72 ,  A61K2300/00

Abstract: Dietary vitamin-mineral supplements featuring various vitamins and minerals for benefiting individuals suffering from conditions such as nutritional deficiencies, vitamin deficiencies, aging, cancer, high blood pressure, high cholesterol, dementia, Alzheimer's disease, coronary artery disease, fatigue, and stroke. Vitamins and minerals may include Vitamin C, Vitamin A, pregnenolone, coenzyme Q10, Vitamin K2, acetyl L-carnitine arginate, L-glutathione, among others.

公开(公告)号：US20150079149A1

公开(公告)日：2015-03-19

申请号：US14547875

申请日：2014-11-19

Applicant: Alessandra Grassi

Inventor： Alessandra Grassi

IPC: A61K9/00 ,  A61K31/525 ,  A61K31/455 ,  A61K31/675 ,  A23L1/302 ,  A61K31/375 ,  A61K31/714 ,  A61K31/4188 ,  A61K45/06 ,  A61K9/70 ,  A61K31/51 ,  A61K31/197

CPC classification number: A61K9/0056 ,  A23L29/20 ,  A23L33/105 ,  A23L33/115 ,  A23L33/15 ,  A23L33/16 ,  A23P20/20 ,  A23V2002/00 ,  A61K9/7007 ,  A61K31/015 ,  A61K31/045 ,  A61K31/07 ,  A61K31/14 ,  A61K31/195 ,  A61K31/197 ,  A61K31/34 ,  A61K31/355 ,  A61K31/375 ,  A61K31/4188 ,  A61K31/44 ,  A61K31/4415 ,  A61K31/455 ,  A61K31/4985 ,  A61K31/51 ,  A61K31/525 ,  A61K31/593 ,  A61K31/675 ,  A61K31/685 ,  A61K31/714 ,  A61K33/06 ,  A61K33/18 ,  A61K33/22 ,  A61K33/24 ,  A61K33/26 ,  A61K33/30 ,  A61K33/32 ,  A61K33/34 ,  A61K45/06 ,  A61K2300/00 ,  A23V2200/334 ,  A23V2250/7042 ,  A23V2250/7044 ,  A23V2250/7046 ,  A23V2250/705 ,  A23V2250/7052 ,  A23V2250/706 ,  A23V2250/708 ,  A23V2250/72

Abstract: A strip, which is both edible and dissolvable, is provided comprising a film and a dosage of at least 2% of the reference daily intake (RDI) of at least one dietary supplement for malnutrition or to prevent/treat alcohol induced hangovers. A method for treating malnutrition and/or preventing and treating alcohol-induced hangovers using a dissolvable orally administered strip.

Abstract translation: 提供既可食用又可溶解的条状物，其包含至少一种营养不良膳食补充剂的参考每日摄入量（RDI）的至少2％的剂量，或用于预防/治疗酒精诱导的宿醉。 一种使用可溶性口服给药条治疗营养不良和/或预防和治疗酒精诱导宿醉的方法。

公开(公告)号：US08911770B2

公开(公告)日：2014-12-16

申请号：US12818692

申请日：2010-06-18

Applicant: Alessandra Grassi

Inventor： Alessandra Grassi

IPC: A61K9/70 ,  A61K9/00 ,  A61K31/525 ,  A61K33/30 ,  A61K33/32 ,  A23L1/00 ,  A23L1/05 ,  A61K31/4985 ,  A61K31/045 ,  A23L1/30 ,  A61K31/375 ,  A61K31/714 ,  A61K31/4188 ,  A61K31/14 ,  A61K33/34 ,  A61K31/355 ,  A61K31/197 ,  A61K31/455 ,  A61K31/44 ,  A61K33/22 ,  A61K33/06 ,  A61K31/685 ,  A61K33/24 ,  A61K33/18 ,  A61K31/07 ,  A61K31/34 ,  A61K31/015 ,  A61K31/195 ,  A23L1/304 ,  A61K31/51 ,  A61K33/26 ,  A61K31/593 ,  A61K31/4415 ,  A61K45/06 ,  A23L1/302

CPC classification number: A61K9/0056 ,  A23L29/20 ,  A23L33/105 ,  A23L33/115 ,  A23L33/15 ,  A23L33/16 ,  A23P20/20 ,  A23V2002/00 ,  A61K9/7007 ,  A61K31/015 ,  A61K31/045 ,  A61K31/07 ,  A61K31/14 ,  A61K31/195 ,  A61K31/197 ,  A61K31/34 ,  A61K31/355 ,  A61K31/375 ,  A61K31/4188 ,  A61K31/44 ,  A61K31/4415 ,  A61K31/455 ,  A61K31/4985 ,  A61K31/51 ,  A61K31/525 ,  A61K31/593 ,  A61K31/675 ,  A61K31/685 ,  A61K31/714 ,  A61K33/06 ,  A61K33/18 ,  A61K33/22 ,  A61K33/24 ,  A61K33/26 ,  A61K33/30 ,  A61K33/32 ,  A61K33/34 ,  A61K45/06 ,  A61K2300/00 ,  A23V2200/334 ,  A23V2250/7042 ,  A23V2250/7044 ,  A23V2250/7046 ,  A23V2250/705 ,  A23V2250/7052 ,  A23V2250/706 ,  A23V2250/708 ,  A23V2250/72

Abstract: A strip, which is both edible and dissolvable, is provided comprising a film and a dosage of at least 2% of the reference daily intake (RDI) of at least one dietary supplement for malnutrition or to prevent/treat alcohol induced hangovers. A method for treating malnutrition and/or preventing and treating alcohol-induced hangovers using a dissolvable orally administered strip.

Abstract translation: 提供既可食用又可溶解的条状物，其包含至少一种营养不良膳食补充剂的参考每日摄入量（RDI）的至少2％的剂量，或用于预防/治疗酒精诱导的宿醉。 一种使用可溶性口服给药条治疗营养不良和/或预防和治疗酒精诱导宿醉的方法。

公开(公告)号：US08846061B1

公开(公告)日：2014-09-30

申请号：US13693563

申请日：2012-12-04

Applicant: Mark S. Bezzek

Inventor： Mark S. Bezzek

IPC: A61K9/00 ,  A61K36/88 ,  A61K36/48 ,  A61K36/45 ,  A61K36/03 ,  A61K31/122 ,  A61K36/68 ,  A61K36/484 ,  A61K36/42 ,  A61K36/54 ,  A61K36/27 ,  A61K36/82 ,  A61K36/258

CPC classification number: A23L1/30 ,  A23L33/10 ,  A23L33/105 ,  A23L33/12 ,  A23L33/15 ,  A23L33/155 ,  A23L33/16 ,  A23L33/18 ,  A23V2002/00 ,  A61K8/31 ,  A61K8/347 ,  A61K8/35 ,  A61K8/355 ,  A61K8/361 ,  A61K8/41 ,  A61K8/4986 ,  A61K8/63 ,  A61K8/64 ,  A61K8/671 ,  A61K8/675 ,  A61K8/676 ,  A61K8/735 ,  A61K8/97 ,  A61K31/05 ,  A61K31/085 ,  A61K31/12 ,  A61K31/122 ,  A61K31/185 ,  A61K31/198 ,  A61K31/205 ,  A61K31/352 ,  A61K31/355 ,  A61K31/375 ,  A61K31/385 ,  A61K31/404 ,  A61K31/4172 ,  A61K31/4188 ,  A61K31/4415 ,  A61K31/4745 ,  A61K31/475 ,  A61K31/48 ,  A61K31/566 ,  A61K31/57 ,  A61K31/575 ,  A61K31/593 ,  A61K31/675 ,  A61K31/736 ,  A61K33/22 ,  A61K33/24 ,  A61K33/30 ,  A61K33/32 ,  A61K36/03 ,  A61K36/15 ,  A61K36/185 ,  A61K36/258 ,  A61K36/27 ,  A61K36/42 ,  A61K36/45 ,  A61K36/47 ,  A61K36/48 ,  A61K36/484 ,  A61K36/54 ,  A61K36/68 ,  A61K36/73 ,  A61K36/82 ,  A61K36/889 ,  A61K36/8962 ,  A61K36/9066 ,  A61Q19/08 ,  A23V2200/322 ,  A23V2250/026 ,  A23V2250/0634 ,  A23V2250/1572 ,  A23V2250/1578 ,  A23V2250/1586 ,  A23V2250/1588 ,  A23V2250/1598 ,  A23V2250/16 ,  A23V2250/161 ,  A23V2250/1612 ,  A23V2250/1614 ,  A23V2250/1626 ,  A23V2250/1642 ,  A23V2250/1866 ,  A23V2250/2106 ,  A23V2250/2112 ,  A23V2250/21166 ,  A23V2250/212 ,  A23V2250/213 ,  A23V2250/214 ,  A23V2250/304 ,  A23V2250/31 ,  A23V2250/314 ,  A23V2250/626 ,  A23V2250/641 ,  A23V2250/702 ,  A23V2250/7042 ,  A23V2250/7044 ,  A23V2250/705 ,  A23V2250/7052 ,  A23V2250/7056 ,  A23V2250/706 ,  A23V2250/708 ,  A23V2250/7106 ,  A23V2250/712 ,  A23V2250/7144 ,  A23V2250/72 ,  A61K2300/00

Abstract: Dietary vitamin-mineral supplements featuring various vitamins and minerals for benefiting individuals suffering from conditions such as nutritional deficiencies, vitamin deficiencies, aging, cancer, high blood pressure, high cholesterol, dementia, Alzheimer's disease, coronary artery disease, fatigue, and stroke. Vitamins and minerals may include Vitamin C, Vitamin A, pregnenolone, coenzyme Q10, Vitamin K2, acetyl L-carnitine arginate, L-glutathione, among others.

Abstract translation: 膳食维生素矿物质补充剂，具有各种维生素和矿物质，有益于患有营养不良，维生素缺乏症，衰老，癌症，高血压，高胆固醇，痴呆，阿尔茨海默病，冠状动脉疾病，疲劳和中风等病症的个体。 维生素和矿物质可包括维生素C，维生素A，孕烯醇酮，辅酶Q10，维生素K2，乙酰左旋肉碱精氨酸，L-谷胱甘肽等。

公开(公告)号：US20140105877A1

公开(公告)日：2014-04-17

申请号：US14058388

申请日：2013-10-21

Applicant: Tima Foundation

Inventor： Markus Graf von MATUSCHKA-GREIFFENCLAU

IPC: A61K31/525 ,  A61K31/194 ,  A61K31/341 ,  A61K31/198 ,  A61K31/122 ,  A61K31/455

CPC classification number: A61K31/525 ,  A23L33/15 ,  A23L33/155 ,  A23L33/175 ,  A23L33/30 ,  A23V2002/00 ,  A61K31/122 ,  A61K31/194 ,  A61K31/198 ,  A61K31/341 ,  A61K31/375 ,  A61K31/445 ,  A61K31/455 ,  A61K45/06 ,  A23V2200/322 ,  A23V2250/7046 ,  A23V2250/708 ,  A23V2250/5114 ,  A23V2250/0618 ,  A23V2250/0616 ,  A23V2250/7044 ,  A23V2250/036 ,  A23V2250/062 ,  A61K2300/00 ,  A23V2250/61 ,  A23V2250/02

Abstract: The present invention is directed to a composition of matter, in particular a food composition, dietary or food supplementation, and pharmaceutical composition, respectively. The composition of matter reduces the risk of neuropathy, neurodegenerative diseases including late-onset Alzheimer's disease, and cancer, in particular of pancreatic, esophageal, oropharyngolaryngeal, liver, colorectal, lung and/or breast cancer, in particular the drug and/or alcohol induced risk of said diseases. In this respect, the present invention is also directed to a composition of matter, in particular a food composition, dietary or food supplementation, and pharmaceutical composition, respectively, which supports and/or moderates the alcohol degradation process within the human body.

Abstract translation: 本发明分别涉及物质的组合物，特别是食物组合物，膳食或食物补充剂和药物组合物。 物质的组成降低了神经病变，神经退行性疾病，包括迟发性阿尔茨海默病和癌症，特别是胰腺，食管，咽喉癌，肝癌，结肠直肠癌，肺癌和/或乳腺癌，特别是药物和/或酒精的风险。 引起所述疾病的风险。 在这方面，本发明还涉及分别支持和/或调节人体内的醇降解过程的物质组合物，特别是食物组合物，膳食或食品补充剂和药物组合物。